Philip Petteruti

808 total citations
7 papers, 210 citations indexed

About

Philip Petteruti is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Philip Petteruti has authored 7 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Hematology. Recurrent topics in Philip Petteruti's work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (1 paper) and Integrated Circuits and Semiconductor Failure Analysis (1 paper). Philip Petteruti is often cited by papers focused on PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (1 paper) and Integrated Circuits and Semiconductor Failure Analysis (1 paper). Philip Petteruti collaborates with scholars based in United States and United Kingdom. Philip Petteruti's co-authors include Olga Tsukurov, Roslyn W. Orkin, Huawei Chen, Eríc F. Grabowski, Armin J. Reininger, Bin Yang, Michelle L. Lamb, Xiahui Zhu, Claudio Chuaqui and Wenxian Wang and has published in prestigious journals such as Clinical Cancer Research, Arteriosclerosis Thrombosis and Vascular Biology and Molecular Cancer Therapeutics.

In The Last Decade

Philip Petteruti

5 papers receiving 208 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Petteruti United States 5 133 71 54 31 26 7 210
G. Wei Xu Canada 7 218 1.6× 19 0.3× 79 1.5× 25 0.8× 31 1.2× 13 252
Grace Wing-Yan Mak Hong Kong 6 128 1.0× 34 0.5× 57 1.1× 16 0.5× 33 1.3× 8 175
Bo Kyung A. Seong United States 7 259 1.9× 23 0.3× 89 1.6× 17 0.5× 42 1.6× 7 331
Josephine Sheedy United States 9 204 1.5× 20 0.3× 69 1.3× 21 0.7× 45 1.7× 20 264
Anjum Zafar Australia 9 299 2.2× 104 1.5× 99 1.8× 21 0.7× 72 2.8× 10 369
Fengbiao Zhou China 11 303 2.3× 31 0.4× 90 1.7× 24 0.8× 102 3.9× 23 367
Takao Morinaga Japan 9 151 1.1× 62 0.9× 70 1.3× 22 0.7× 29 1.1× 23 229
Smit Shah United States 6 202 1.5× 45 0.6× 31 0.6× 57 1.8× 5 0.2× 11 275
Amanda L. Robichaud United States 7 280 2.1× 17 0.2× 105 1.9× 36 1.2× 47 1.8× 9 370
Louis Masclef Canada 5 138 1.0× 14 0.2× 50 0.9× 12 0.4× 33 1.3× 9 194

Countries citing papers authored by Philip Petteruti

Since Specialization
Citations

This map shows the geographic impact of Philip Petteruti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Petteruti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Petteruti more than expected).

Fields of papers citing papers by Philip Petteruti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Petteruti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Petteruti. The network helps show where Philip Petteruti may publish in the future.

Co-authorship network of co-authors of Philip Petteruti

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Petteruti. A scholar is included among the top collaborators of Philip Petteruti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Petteruti. Philip Petteruti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hemsley, Paul, et al.. (2020). Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors. ACS Chemical Biology. 15(2). 325–333. 22 indexed citations
2.
Yeh, Tammie C., Greg O’Connor, Philip Petteruti, et al.. (2017). Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors. Clinical Cancer Research. 23(4). 1025–1035. 16 indexed citations
3.
Mayo, Michele, Shaun Grosskurth, Xin Wang, et al.. (2013). Abstract A221: Novel PARP6 inhibitors demonstrate in vivo efficacy in xenograft models.. Molecular Cancer Therapeutics. 12(11_Supplement). A221–A221.
4.
Wu, Jiaquan, Keith Mikule, Wenxian Wang, et al.. (2013). Discovery and Mechanistic Study of a Small Molecule Inhibitor for Motor Protein KIFC1. ACS Chemical Biology. 8(10). 2201–2208. 85 indexed citations
5.
Grosskurth, Shaun, Philip Petteruti, Xin Wang, & Keith Mikule. (2013). Abstract A134: Functional perturbation of PARP6 affects centromeric proteins and is associated with increased multi-polar spindles in breast cancer cell lines.. Molecular Cancer Therapeutics. 12(11_Supplement). A134–A134.
6.
Jenkins, David W., Sarah J. Ross, Margaret H. Veldman-Jones, et al.. (2012). MEDI0639: A Novel Therapeutic Antibody Targeting Dll4 Modulates Endothelial Cell Function and Angiogenesis In Vivo. Molecular Cancer Therapeutics. 11(8). 1650–1660. 47 indexed citations
7.
Grabowski, Eríc F., Armin J. Reininger, Philip Petteruti, Olga Tsukurov, & Roslyn W. Orkin. (2001). Shear Stress Decreases Endothelial Cell Tissue Factor Activity by Augmenting Secretion of Tissue Factor Pathway Inhibitor. Arteriosclerosis Thrombosis and Vascular Biology. 21(1). 157–162. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026